.

Aptinyx Inc reported $24.5M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Biogen BIIB:US $ 6277.4M 1.7M
Cara Therapeutics CARA:US $ 0 0
Daiichi Sankyo 4568:JP Y 142973M 94M
Eli Lilly And LLY:US $ 14692M 460.9M
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 23784M 589M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M